China Shortage Of Pediatric Drugs Leaves 220 Million Children Exposed
This article was originally published in PharmAsia News
Executive Summary
China State FDA says the nation's 220 million children under the age of 14 years of age experience double the rate of adverse drug effects, primarily because their treatment relies on drugs designed for adults.